Back to full study details
Palo Alto, CANow Enrolling

Ovarian Cancer Clinical Trial in Palo Alto, CA

Access cutting-edge ovarian cancer treatment through this clinical trial at a research site in Palo Alto. Study-provided care at no cost to qualified participants.

Expert Care

Access ovarian cancer specialists in Palo Alto at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related ovarian cancer treatment provided free

About This Ovarian Cancer Study in Palo Alto

A Phase 2 study to evaluate the safety and efficacy of TORL-1-23 in patients with advanced ovarian cancer.

Sponsor: TORL Biotherapeutics, LLC

Apply for This Palo Alto Location

Check if you qualify for this ovarian cancer clinical trial in Palo Alto, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Ovarian Cancer Treatment Options in Palo Alto, CA

If you're searching for ovarian cancer treatment options in Palo Alto, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Palo Alto research site is actively enrolling participants for this clinical trial. You'll receive care from experienced ovarian cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Why Consider a Clinical Trial for Ovarian Cancer?

  • Access to new treatments before they're widely available
  • Receive care from leading ovarian cancer specialists in Palo Alto
  • Contribute to medical research that could help future patients
  • Study-related care is typically provided at no cost
  • Close monitoring by a dedicated research team
  • Possible compensation for time and travel